RN7SKP111

Q-omics provides the consensus-scored RN7SKP111 profile across patient tissues and cancer cell-line models. RN7SKP111 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, RN7SKP111 RNA expression shows 5,758 significant gene co-expression associations, with the highest sampling consensus in COAD. Together, these results highlight BLCA, and COAD as cancer lineages where RN7SKP111 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes RN7SKP111 survival associations across molecular data types. RN7SKP111 RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RN7SKP111 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	BLCA (36)	view →

This table ranks reproducible RN7SKP111 RNA expression–survival associations across cancer types. High RN7SKP111 expression shows unfavorable associations in BLCA. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for RN7SKP111 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	IV	0.074	0.599	<.001	36	view →

Pink = unfavorable, green = favorable. all 1 lineages →

RN7SKP111-BLCA (OS)

Explore this curve interactively →